Physician profile
David L Lawrence
NPI 1245219989
$3,164.29
in general payments reported to CMS, 2019-2025
19 companies · $509 in 2025
The $509 reported for 2025 was more than what a typical Nuclear Cardiology provider received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $587 · 2020: $240 · 2021: $863 · 2022: $65.63 · 2023: $564 · 2024: $335 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,388 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,388.43 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $679.53 | 2021 | |
| Boston Scientific Corporation | $402.09 | 2019-2025 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $338.79 | 2019-2023 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $275.61 | 2019-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $215.87 | 2023-2025 | Assure Wcd |
| Amgen INC. | $204.16 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $186.93 | 2023-2025 | Ensite |
| Sanofi-Aventis U.S. LLC | $159.84 | 2019 | |
| Irhythm Technologies, INC. | $143.41 | 2023 | Zio Xt Patch |
| Astrazeneca Pharmaceuticals Lp | $140.47 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $111.36 | 2019-2021 | |
| Atricure, INC. | $92.79 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.24 | 2022-2025 | Lifevest |
| Amarin Pharma, INC. | $43.03 | 2019-2020 | |
| Esperion Therapeutics, INC. | $25.03 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.22 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $14.07 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.97 | 2019 | |
| Pfizer INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.